Home > Groups > ALS 333 DMD Project

ALS 333 DMD Project

Recently Added Items

Title	Added By	Updated On
Biopharmaceutical Industry-Sponsored Clinical Trials: Impact on State Economies	caitiestaat	Nov 30, 2015 9:43:01 PM
Guidance for Industry: Expedited Programs for Serious Conditions - Drugs and Biologics	caitiestaat	Nov 30, 2015 9:39:39 PM
Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies	caitiestaat	Nov 30, 2015 9:38:28 PM
Food and Drug Administration Safety and Innovation Act (FDASIA) - Frequently Asked Questions: Breakthrough Therapies	caitiestaat	Nov 30, 2015 9:36:23 PM
Orphan Drug Act	caitiestaat	Nov 30, 2015 9:22:36 PM
OpportunityAnalyzer: Duchenne Muscular Dystrophy – Opportunity and Market Analysis to 2019	aborenstein15	Nov 30, 2015 9:03:07 PM
National Vital Statistic Reports-Births: Final Data for 2013	aborenstein15	Nov 30, 2015 9:02:37 PM
Exon skipping therapy for Duchenne muscular dystrophy	Mandar Makwana	Nov 29, 2015 8:39:32 AM
Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy	aborenstein15	Nov 29, 2015 6:39:30 AM
Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations	aborenstein15	Nov 29, 2015 6:35:13 AM

See all 29 items for this group in the Group Library.